Zeo ScientifiX, Inc. (ZEOX) stock
ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026Market cap $7.08MP/E –Yield –
Zeo ScientifiX revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Zeo ScientifiX's revenue for the twelve months ending Apr 30, 2026 was $6.99M. For fiscal 2025 it was $5.20M, up 12.5% from the year before. Over ten years it grew 42.8% a year on average. The highest annual figure on record is $6.49M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $5.20M | +12.5% |
| FY2024 | Oct 31, 2024 | $4.62M | +1.4% |
| FY2023 | Oct 31, 2023 | $4.56M | -29.8% |
| FY2022 | Oct 31, 2022 | $6.49M | +16.0% |
| FY2021 | Oct 31, 2021 | $5.60M | +83.2% |
| FY2020 | Oct 31, 2020 | $3.06M | +79.5% |
| FY2019 | Oct 31, 2019 | $1.70M | +76.5% |
| FY2018 | Oct 31, 2018 | $964.53K | +69.3% |
| FY2017 | Oct 31, 2017 | $569.85K | +208.2% |
| FY2016 | Oct 31, 2016 | $184.88K | +25.2% |
| FY2015 | Oct 31, 2015 | $147.63K | +200.1% |
| FY2014 | Oct 31, 2014 | $49.20K | -40.7% |
| FY2013 | Oct 31, 2013 | $82.97K | -4.8% |
| FY2012 | Oct 31, 2012 | $87.15K | +382.0% |
| FY2011 | Oct 31, 2011 | $18.08K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $2.58M | +124.6% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $1.45M | +32.7% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $1.65M | +46.2% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $1.31M | +13.2% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $1.15M | -19.2% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $1.09M | -10.7% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $1.13M | -21.6% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $1.15M | -32.6% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $1.42M | -18.0% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $1.22M | -23.6% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $1.44M | -13.4% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $1.71M | +25.2% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $1.74M | +76.5% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $1.60M | +108.4% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $1.67M | +173.9% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $1.37M | +96.3% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $983.27K | +67.9% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $767.33K | +32.6% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $608.23K | +145.1% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $696.95K | +238.0% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $585.64K | +532.7% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $578.71K | +38.6% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $248.14K | -5.5% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $206.20K | +23.7% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $92.56K | -33.9% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $417.63K | +71289.7% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $262.62K | +723.9% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $166.64K | +574.4% |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $140.01K | +109.9% |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $585 | -99.1% |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $31.88K | -72.4% |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | $24.71K | -22.8% |
| Q2 FY2016CQ1 2016 | Apr 30, 2016 | $66.70K | – |
| Q1 FY2016CQ4 2015 | Jan 31, 2016 | $61.60K | – |
| Q4 FY2015CQ3 2015 | Oct 31, 2015 | $115.63K | – |
| Q3 FY2015CQ2 2015 | Jul 31, 2015 | $32.00K | – |
See a number that looks wrong?